Category: Antisense & RNAi Technology
North America Antisense & RNAi Technology
-
Antisense and RNAi Therapeutics
... reach US$3.6 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2023-2030. Antisense RNA Technology, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and ... Read More
-
North America RNA Therapeutics Market, By Product (Vaccines, Drugs), By Type (mRNA Therapeutics, RNA Interference (RNAi) Therapeutics, Antisense Oligonucleotide (ASO) Therapeutics, Other Therapeutics), By Indication (Infectious Diseases, Rare Genetic Diseases/Hereditary Diseases, Other Indications), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), By Country, Competition, Forecast and Opportunities, 2019-2029F
... User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), By Country, Competition, Forecast and Opportunities, 2019-2029F North America RNA Therapeutics Market was valued at USD 12.95 billion in 2023 and is anticipated to project robust growth ... Read More
-
Rnai Technology Market, By Application (Drug Discovery and Development, Therapeutics, Functional Genomics, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs & CMOs, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Asia Pacific, Middle East & Africa) Global RNAi technology market growth is driven by growing applications of RNA interference technology in therapeutics development and research. RNA interference or RNAi refers to the process of gene ... Read More
-
United States RNAi Therapeutics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... States market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the United States market. Also, factors that are driving and restraining the RNAi therapeutics market are ... Read More
-
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Treatment Market, By Type (Hereditary Transthyretin Amyloidosis (hATTR), Wild Type Transthyretin Amyloidosis (wtATTR)), By Drug Type (Transthyretin Stabilizers, Nonsteroidal Anti-Inflammatory Drugs (NSAID), RNAi Therapy, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific) Transthyretin amyloid ardiomyopathy (ATTR-CM) is a rare and serious medical condition characterized by the abnormal accumulation of transthyretin ... Read More
-
North America Genome Editing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CRISPR, TALEN, Antisense, and Other), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
... User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations) The genome editing market in North America is expected to grow from US$ 2,136.41 million in 2021 to US$ 7,024.71 million by ... Read More
-
North America RNA Based Therapeutic Market By Type (RNA Antisense and RNA Interference (RNAi)), By Application (Genetic disorders and Auto immune disorders), By End User (Research Institutes and Hospitals & Clinics), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027
... and Industry Forecast, 2021 - 2027 The North America RNA Based Therapeutic Market would witness market growth of 14.8% CAGR during the forecast period (2021-2027). RNA polymerase synthesizes RNA from template DNA, with messenger RNA ... Read More
Research Assistance
